Opening book details…
Can I read Utility of HAS-BLED and CHA2DS2-VASc Scores Among Patients With Atrial Fibrillation and Imaging Evidence of Cerebral Amyloid Angiopathy on EtoBox?
Utility of HAS-BLED and CHA2DS2-VASc Scores Among Patients With Atrial Fibrillation and Imaging Evidence of Cerebral Amyloid Angiopathy by Robert Ward; Shiva Ponamgi; Christopher V. DeSimone; Stephen English; David O. Hodge; Joshua P. Slusser; Jonathan Graff-Radford; Alejandro A. Rabinstein; Samuel J. Asirvatham; David Holmes is a Medicine article available to read on EtoBox.
What is Utility of HAS-BLED and CHA2DS2-VASc Scores Among Patients With Atrial Fibrillation and Imaging Evidence of Cerebral Amyloid Angiopathy about?
Objective: To determine the utility of the HAS-BLED (Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly, Drugs/alcohol concomitantly) and CHA 2 DS 2 -VASc (Congestive heart failure, Hypertension, Age, Diabetes, previous Stroke/transient ischemic attackeVAScular disease) scores among patients on anticoagulation (AC) therapy for atrial fibrillation (AF) who have evidence of cerebral amyloid angiopathy (CAA). Patients and Methods: Patients older than 55 years with a diagnosis of AF who had a nontraumatic intracerebral hemorrhage (ICH) while on AC therapy between 1995 and 2016 were identified using the Rochester Epidemiology Project Database. Medical records were reviewed, including imaging of the brain, to identify baseline characteristics, AC use, and outcomes. Results: A total of 65 patients were identified (mean age, 81.3 years); 35 (53.8%) had evidence of possible/probable CAA. Mean HAS-BLED score in the CAA group was significantly lower (2.1) than that of the non-CAA group (2.9; P<.001). Mortality after ICH, adjusted for HAS-BLED scores, was not significantly different among patients with and wit
Who reads Utility of HAS-BLED and CHA2DS2-VASc Scores Among Patients With Atrial Fibrillation and Imaging Evidence of Cerebral Amyloid Angiopathy?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Robert Ward; Shiva Ponamgi; Christopher V. DeSimone; Stephen English; David O. Hodge; Joshua P. Slusser; Jonathan Graff-Radford; Alejandro A. Rabinstein; Samuel J. Asirvatham; David Holmes
- Publisher
- Mayo Clinic; Elsevier ; Elsevier BV (ISSN 0025-6196)
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)